Original language | English |
---|---|
Publication status | Accepted/In press - 30 Aug 2019 |
InflaMab: A novel inhibitor of inflammation targeting the NLRP3 Inflammasome
Research output: Contribution to conference › Abstract › peer-review
109
Downloads
(Pure)